TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?-Reference-Cited by-同舟云学术

TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?

Published:2003-05 Issue:5 Volume:22 Page:501-504
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Mehra Mandeep R,Uber Patricia A

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference30 articles.

1. Perspectives on cardiac allograft vasculopathy;Young;Curr Atheroscler Rep,2000

2. Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients;Eisen;J Heart Lung Transplant,2002

3. Keogh A. Immunosuppression: an evolving art and science. TOR inhibitors. Rapamycin: results of a randomized trial following heart transplantation. Program and abstracts of the International Society for Heart and Lung Transplantation 22nd Annual Meeting and Scientific Sessions, April 10–13, 2002, Washington DC

4. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy;Mehra;J Heart Lung Transplant,1997

5. The status of cardiac transplantation, 1975;Rider;Circulation,1975

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy;Progress in Cardiovascular Diseases;2020-05

2. Cardiac allograft vasculopathy: A review;Catheterization and Cardiovascular Interventions;2018-09-28

3. Pathophysiology and treatment options of chronic renal allograft damage;Nephrology Dialysis Transplantation;2013-04-25

4. Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus-Results of a Multicenter Trial;American Journal of Transplantation;2012-09-07

5. Cardiac Allograft Vasculopathy;Reviews in Cardiovascular Medicine;2011-09-30